Results 201 to 210 of about 84,355 (327)

Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphoma. [PDF]

open access: yesBlood Adv
Querfeld C   +14 more
europepmc   +1 more source

Metastatic Squamous Cell Carcinoma Treated With Pembrolizumab in a Patient With Xeroderma Pigmentosum

open access: yesPediatric Dermatology, EarlyView.
ABSTRACT A 5‐year‐old male with xeroderma pigmentosum from Honduras presented with a rapidly growing mass on the left post‐auricular neck, associated with left‐sided hearing loss. MRI revealed a large mass with invasion of the external auditory canal, temporal bone, and metastasis to lymph nodes. Biopsy confirmed moderately differentiated squamous cell
Ngan Do   +4 more
wiley   +1 more source

Prognosis and Staging of Cutaneous T-cell Lymphoma

open access: hybrid, 1995
Francine M. Foss, Edward A. Sausville
openalex   +1 more source

Fine-Needle Aspiration Biopsy in the Evaluation of Lymphadenopathy Associated With Cutaneous T-Cell Lymphoma (Mycosis Fungoides/Sézary Syndrome) [PDF]

open access: bronze, 2000
Lorenzo M. Galindo   +6 more
openalex   +1 more source

Memory T-Cell Phenotype in Cutaneous T-Cell Lymphoma Is Modified by Germline Gene Gametocyte Specific Factor 1. [PDF]

open access: yesExp Dermatol
Martínez Villarreal A   +5 more
europepmc   +1 more source

Polo‐like kinases and UV‐induced skin carcinogenesis: What we know and what's next

open access: yesPhotochemistry and Photobiology, EarlyView.
The polo‐like kinase (PLK) family plays distinct and critical roles in the regulation of cell cycle progression, and its dysregulation has been implicated in various cancers. Ultraviolet (UV) radiation is a well‐established environmental factor in the development of skin cancer.
Tanya Jaiswal   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy